3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
HIV Infections
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Renal Cell
1
Interventions
venetoclax
14
ibrutinib
11
Rituximab
9
obinutuzumab
8
Specimen Handling
7
Cyclophosphamide
7
acalabrutinib
6
Biopsy
6
zanubrutinib
5
pirtobrutinib
5
fludarabine phosphate
4
Lenalidomide
4
ARQ531
4
idelalisib
3
Whole-Body Irradiation
3
Magnetic Resonance Spectroscopy
3
Cyclosporine
3
fludarabine
2
Vincristine
2
Sirolimus
2
Prednisone
2
Mycophenolic Acid
2
Doxorubicin
2
CT-P10
2
Bendamustine Hydrochloride
2
treosulfan
1
tocilizumab
1
pembrolizumab
1
mirdametinib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Health Promotion
×
30 days
×
Clear all
No trials found.